Navigation Links
Personalized Medicine - The Genomic Revolution in Cardiac Care
Date:9/19/2007

WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ --The Richard B. and Lynne V. Cheney Cardiovascular Institute and The Catherine Birch McCormick Genomics Center at The George Washington University host a cutting edge Symposium to examine the issues and implications around the growing forces of genomics and personalized medicine in cardiology. This symposium is intended to provide a valuable state-of-the-art update on the current status and future directions of the genomics of atherosclerotic cardiovascular disease, heart failure and cardiac arrhythmias, and the potential application to individualizing prevention, diagnosis and treatment for cardiac patients.

The practice of cardiovascular care has seen significant advances in the past 40 years with dramatic reduction of mortality from heart disease. Despite this major progress, cardiovascular disease remains the number one cause of death in the United States and is on the rise in developing countries. As we enter the 21st century there is much more we need to learn about the individualized patient disease susceptibility, progression, and treatment strategies. Medical molecular genetics is the next frontier with the potential to make dramatic breakthroughs in the prediction of disease and improvement of prevention, treatment, and quality of care.

The symposium agenda features luminaries in the field of genomics who will explore the state of cardiovascular genomics and how it relates to clinical practice. Keynote speakers include Elizabeth Nabel, MD, Director, National Heart, Lung, and Blood Institute to address: Genomics & Coronary Artery Disease, and Andrew Plump, MD, Ph.D., Director of Clinical Molecular Profiling, Merck & Co., to discuss: Genomics for Developing Biomarkers. The symposium provides a unique forum in its roster of prestigious speakers from academic, government and industry and in its ability to examine the issues and stimulate new ideas around personalized medicine as it relates to personalized cardiovascular care. Researchers, cardiologists, policy makers, medical industry and anyone with an interest in personalized medicine and genomics will want to attend.

"By identifying the genes that can cause and cure heart disease, researchers hold in their hands the potential for personalized medicine. Understanding research advances in the science of the human gene and its application to cardiovascular disease will make possible life saving changes in cardiac care," says Dr. Timothy McCaffrey, who is the program co-chair for the one-day symposium as well as director of the McCormick Genomics Center at The George Washington University. The McCormick Genomics Center is among the nation's innovative leaders in genomics research and application and is one of the few centers in the world to focus on cardiovascular genomic research. Dr. McCaffrey will lead a faculty of renowned experts, in the program.

"Leveraging the enormous resources of The George Washington University is a key part of how the Institute is approaching its mission to accelerate the pace of scientific discovery, reduce mortality and improve the quality of life of Americans with cardiovascular disease," said Dr. Richard J. Katz, who is the Director of the Cheney Cardiovascular Institute and Director of the Division of Cardiology. "An educational program like this one, on personalized medicine in cardiac care, holds the key to the next major advancements in cardiovascular care, which researchers, clinicians and policy makers must understand is one of the ways we're attacking cardiovascular disease and working to achieve our mission."

The symposium, titled "Personalized Medicine: The Genomic Revolution in Cardiac Care," is designated for 6 AMA PRA Category 1 Credits and will convene on October 25, 2007 at The George Washington University Hospital Auditorium, in Washington, DC. For more information about the symposium or to register, please visit http://www.cheneycardioinstitute.org.

ABOUT THE CHENEY CARDIOVASCULAR INSTITUTE

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006. The Institute's mission is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health-policy experts, and community leaders. For more information, please visit: http://www.cheneycardioinstitute.org.


'/>"/>
SOURCE The Cheney Cardiovascular Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
2. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
3. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
4. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
5. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
6. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
9. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
10. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
11. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017 Report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. ... Market data and analytics are derived from primary and secondary ...
(Date:2/24/2017)... from Pharma To Market Pty Ltd and Ador Consulting Pte Ltd ... founding of Pharma To Market Pte Ltd, based in ... announce their expansion into Asia with the ... company are delighted to appoint Joelle Chia , former owner ... based entity. Joelle brings with her an extensive business network ...
(Date:2/24/2017)... , Feb. 23, 2017  The particle counters ... by 2021 from USD 275.9 million in 2016, ... the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... on pharmaceutical R&D, and growth in manufacturing industries ... market growth for particle counters. On the other ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... 27, 2017 , ... Silicon Valley Hair Institute, a professional ... upgrade to the company's Yelp listing. Bay Area residents struggling from thinning hair ... Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit Extraction ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ... in 2011 the lab became the world’s first to be ISO/IEC 17025:2005 INAB ... (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets ...
(Date:2/26/2017)... KS (PRWEB) , ... February ... ... StaffBridge sets a new technology standard in staffing, scheduling, and reporting for ... monitor, and predict activity throughout the entire staffing process. StaffBridge technology improves ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have ... from Pixel Film Studios. With ProSharpen Color users have total control over sharpening amount, ... their color range. With color spectrum tools users can visually see the color range ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , ... and recognition opportunities as well as advocacy for the state and region‘s technology ... February 23. The Council's Innovation Forecast event highlights innovation throughout the region ...
Breaking Medicine News(10 mins):